HCPLive

Smoking Bans Lead to Less, Not More, Smoking at Home

Smoke-free legislation leads to less smoking in smokers' homes, not more, according to research published online Feb. 13 in Tobacco Control.

Ute Mons, M.D., of the German Cancer Research Center in Heidelberg, and colleagues conducted a prospective panel study to measure changes in prevalence and predictors of home smoking bans among smokers in Ireland, France, Germany, and the Netherlands after smoke-free legislation was implemented. Survey responses from the United Kingdom were used as a control.

A total of 4,634 survey responses from countries where smoke-free legislation had been implemented, and 1,080 responses from the control country were received. The researchers found that, in all four countries where smoke-free legislation was implemented, the proportion of smokers with a total home smoking ban increased significantly; and in three of the four countries, the number of cigarettes smoked per day either stabilized or decreased for those who continued to smoke. Those who banned smoking in their homes after legislation implementation were more likely to do so if they were already planning to quit smoking, had a small child or were expecting the birth of a child, or if smoking in bars was already banned.

"Our findings strongly support the premise that smoke-free legislation does not lead to more smoking in smokers' homes. The data suggest rather that smoke-free legislation may stimulate smokers to establish total smoking bans in their homes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.id

Most Popular

Recommended Reading

Treating patients with migraines and psychiatric comorbidities can require a delicate balancing act of medications and other forms of therapy.
In many cases helping patients manage their migraine headaches can prove to be enough of a challenge. Adding psychiatric conditions to the diagnosis can further complicate the treatment process for doctors.
Patients with exocrine pancreatic insufficiency treated with pancreatin for up to one year experienced improvements in gastrointestinal symptoms and reduction in the severity of their recurrent pain.
Pre-exposure prophylaxis (PrEP) is a strategy with significant historical precedent in the infectious disease field. Applied to HIV prevention, at-risk individuals would take PrEP to protect against HIV acquisition in case of any planned or unplanned exposure, potentially permitting HIV prophylactic control by the uninfected individual.
$vAR$